Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 33.65
+0.35 (1.05%)
May 29, 2026, 1:18 PM CST
Level Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 77.15 | 79.7 | 64.81 | 62.91 | 58.47 | 68.18 |
Depreciation & Amortization | 22.63 | 22.46 | 21.22 | 19.72 | 19.5 | 19.79 |
Loss (Gain) From Sale of Assets | -0.05 | 0 | -0.02 | -0.1 | -0.08 | 0.13 |
Loss (Gain) From Sale of Investments | -1.01 | -8.22 | - | - | - | - |
Provision & Write-off of Bad Debts | -0.03 | -0.03 | -0.06 | 0.24 | - | - |
Other Operating Activities | 2.07 | 1.19 | -0.19 | 2 | -3.7 | 1.37 |
Change in Accounts Receivable | -14.53 | -43.69 | -2 | 6.5 | -22.98 | 56.35 |
Change in Inventory | -19.05 | -17.51 | -9.24 | -15.39 | -17.53 | 7.36 |
Change in Accounts Payable | -5.83 | 14.77 | 2.55 | -14.8 | 17.36 | -25.79 |
Change in Unearned Revenue | -1.81 | 0.93 | -1.11 | 3.21 | 23.04 | 18.53 |
Change in Other Net Operating Assets | 3.51 | 10.02 | -11.86 | 5.91 | -9 | 10.03 |
Operating Cash Flow | 63.9 | 59.61 | 64.1 | 70.21 | 65.07 | 155.95 |
Operating Cash Flow Growth | -21.56% | -7.00% | -8.71% | 7.90% | -58.27% | 87.38% |
Capital Expenditures | -30.4 | -32.67 | -223.68 | -7.67 | -6.74 | -9.16 |
Sale of Property, Plant & Equipment | 0.09 | - | 0.03 | 0.23 | 0.15 | - |
Other Investing Activities | -5.19 | -6.27 | 7.54 | -3.46 | -3.6 | 0.37 |
Investing Cash Flow | -34.64 | -38.93 | -216.11 | -10.9 | -10.19 | -8.79 |
Long-Term Debt Repaid | - | -4.7 | -4.57 | -3.12 | -2.69 | -2.66 |
Net Debt Issued (Repaid) | -4.87 | -4.7 | -4.57 | -3.12 | -2.69 | -2.66 |
Common Dividends Paid | -58.42 | -58.42 | -55.17 | -55.17 | -61.66 | -51.93 |
Other Financing Activities | - | - | -2.88 | 2.88 | - | 0.06 |
Financing Cash Flow | -63.28 | -63.12 | -62.62 | -55.4 | -64.35 | -54.52 |
Net Cash Flow | -34.02 | -42.44 | -214.62 | 3.91 | -9.46 | 92.64 |
Free Cash Flow | 33.5 | 26.94 | -159.58 | 62.54 | 58.33 | 146.8 |
Free Cash Flow Growth | - | - | - | 7.22% | -60.26% | 81.93% |
Free Cash Flow Margin | 4.66% | 3.66% | -21.82% | 9.47% | 9.84% | 21.67% |
Free Cash Flow Per Share | 1.03 | 0.82 | -4.89 | 1.92 | 1.79 | 4.49 |
Cash Interest Paid | 0.2 | 0.2 | 0.28 | 0.33 | 0.35 | 0.38 |
Cash Income Tax Paid | 16.61 | 16.61 | 16.26 | 13.74 | 17.91 | 15.35 |
Levered Free Cash Flow | 10.92 | 6.06 | -175.08 | 40.7 | 40.94 | 127.71 |
Unlevered Free Cash Flow | 11.03 | 6.19 | -174.9 | 40.91 | 41.15 | 127.95 |
Change in Working Capital | -36.86 | -35.48 | -21.66 | -14.56 | -9.11 | 66.48 |